Pfizer CEO granted cash-settled phantom stock units

BOURLA ALBERT reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

BOURLA ALBERT reported acquisition or exercise transactions in this Form 4 filing.

Pfizer Chairman & CEO Albert Bourla received a grant of 24 Phantom Stock Units SSP on July 15, 2026, at a reported transaction price of $24.82 per unit. Each unit represents one phantom share of common stock under Pfizer's Nonfunded Deferred Compensation and Supplemental Savings Plan.

The phantom units are settled in cash after Bourla's separation from service and may be transferred into an alternative investment account at any time. Following this grant, he holds 772,901 phantom stock units directly under the plan.

Insider Trade Summary

Grant/Award: 24 shares

Grant/Award 1 txn

Insider BOURLA ALBERT

Role Chairman & CEO

Type	Security	Shares	Price	Value
Grant/Award	Phantom Stock Units SSP F1, F2	24	$24.82	$595.68

Holdings After Transaction: Phantom Stock Units SSP — 772,901 contracts (Direct)

Footnotes (2)

1. F1. Each unit represents one phantom share of common stock.
2. F2. These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time.

Key Figures

Phantom stock units granted: 24 units Transaction price per unit: $24.82 Total phantom units after grant: 772,901 units

3 metrics

Phantom stock units granted 24 units Phantom Stock Units SSP granted to Albert Bourla on July 15, 2026

Transaction price per unit $24.82 Reported transaction price per Phantom Stock Unit SSP

Total phantom units after grant 772,901 units Total Phantom Stock Units SSP held directly after the reported grant

Key Terms

Phantom Stock Units SSP, Nonfunded Deferred Compensation and Supplemental Savings Plan, separation from service

3 terms

Phantom Stock Units SSP financial

"Security title reported as "Phantom Stock Units SSP" representing phantom shares"

Nonfunded Deferred Compensation and Supplemental Savings Plan financial

"Acquired under the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan"

separation from service financial

"Units are settled in cash following the reporting person's separation from service"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Pfizer (PFE) report for Albert Bourla?

Pfizer reported that Chairman & CEO Albert Bourla received a grant of 24 Phantom Stock Units SSP on July 15, 2026, at a reported price of $24.82 per unit. These are cash-settled phantom units tied to Pfizer common stock.

What are Phantom Stock Units SSP in Pfizer (PFE)'s Form 4?

Phantom Stock Units SSP are awards where each unit represents one phantom share of Pfizer common stock. They are issued under Pfizer’s Nonfunded Deferred Compensation and Supplemental Savings Plan and are ultimately settled in cash, not in actual shares.

How many phantom stock units does Albert Bourla hold after this Pfizer (PFE) grant?

After this grant, Albert Bourla holds 772,901 Phantom Stock Units SSP directly under Pfizer’s deferred compensation plan. The reported 24-unit award modestly increases his existing phantom stock balance within that plan structure.

How and when are Pfizer (PFE) phantom stock units for Albert Bourla settled?

The phantom stock units are settled in cash following Albert Bourla’s separation from service. Under the plan, these units track Pfizer’s common stock value but are paid out in cash rather than stock when his service ends.

Can Albert Bourla reallocate his Pfizer (PFE) phantom stock units?

Yes. The filing states that these phantom stock units may be transferred into an alternative investment account at any time. This allows Bourla to shift value within Pfizer’s Nonfunded Deferred Compensation and Supplemental Savings Plan.

Does this Pfizer (PFE) Form 4 show Albert Bourla buying or selling common stock?

No. The Form 4 reports a grant of cash-settled phantom stock units, not an open-market purchase or sale of Pfizer common shares. The units represent phantom shares and are paid in cash under the deferred compensation plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/16/2026 - 06:17 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

BOURLA ALBERT

(Last) (First) (Middle)

66 HUDSON BOULEVARD EAST

ATTN: CORPORATE SECRETARY

(Street)

NEW YORK NEW YORK 10001-2192

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
PFIZER INC [ PFE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chairman & CEO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/15/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Phantom Stock Units SSP	(1)	07/15/2026		A		24		(2)	(2)	Common Stock	24	$24.82	772,901	D

Explanation of Responses:

1. Each unit represents one phantom share of common stock.

2. These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time.

	/s/ Shanice A. Reid, by power of atty., for Albert Bourla	07/16/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)